The impact of MHCII expression on α-synuclein toxicity in the rat brain
Parkinson’s disease (PD) is the second most common neurodegenerative disorder and is characterized by a progressive loss of dopaminergic neurons (DNs) in substantia nigra pars compact and accumulation of aggregated forms of the protein α-synuclein known as Lewy Bodies (LBs). LBs are present in surviving DNs and other regions of the central nervous system (CNS) in PD patients. PD patients also disp